3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
6
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
48
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
11
Prostatic Neoplasms
7
Gastrointestinal Neoplasms
5
Colorectal Neoplasms
4
cyclopia sequence
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Pleural Effusion, Malignant
2
Pain
2
Mesothelioma
2
Melanoma
2
Lung Diseases
2
Lung Cancer Screening
2
Colonic Neoplasms
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Tobacco Use Cessation
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Smoking Cessation
1
Smoke Inhalation Injury
1
Small Cell Lung Carcinoma
1
Sleepiness
1
Sarcoma
1
Respiratory Aspiration
1
Radiation Pneumonitis
1
Pseudomyxoma Peritonei
1
Interventions
Paclitaxel
12
pembrolizumab
7
Carboplatin
7
Cisplatin
6
Docetaxel
5
sargramostim
4
Taxes
4
Cyclophosphamide
4
Amifostine
4
Trastuzumab
3
Polymerase Chain Reaction
3
Nivolumab
3
Irinotecan
3
Gemcitabine
3
Etoposide
3
talazoparib
2
aldesleukin
2
Vorinostat
2
Vinorelbine
2
SS1(dsFv)PE38
2
Pemetrexed
2
Interleukin-12 Subunit p35
2
Interleukin-12
2
Immunoenzyme Techniques
2
Gene Expression Profiling
2
Flow Cytometry
2
Filgrastim
2
Erlotinib Hydrochloride
2
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Surveys and Questionnaires
×
Thoracic
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled